Helsinki Innovation Services Ltd is located on every campus of the University of Helsinki. Below you will find contact information and detailed profiles of our team members.
Jari Strandman is specialised in the commercialisation of ideas and inventions. He has gained extensive experience in business development, partnerships and internationalisation of startup companies, as an entrepreneur and board member, in Finland, Canada and the UK.
Jari’s strong international business experience is based on working with large, international technology corporations, such as Sisu and Partek Cargotec, as well as small and medium size companies. Strandman is also known for co-founding a numerous university-based startups in Finland and abroad.
Jari has a long experience in the commercialisation of ideas and inventions not only from Finnish universities, but also from working with MIT Industrial Liaisons Program, and from working for Scientific Research Capital Ltd in Oxford. He started collaborating with the University of Helsinki already in 2008, during his assignment as the Managing Director of IP Finland.
Mobile +358 40 700 6968
Milla Koistinaho serves as the Chief Operating Officer (COO) at HIS. Process owners in invention and idea evaluation and enhancement, preparation for commercialization and new business creation as well as commercialization officers at HIS report to Milla. In addition to her COO duties, Milla leads the IP protection and commercialization process.
Milla has over 17 years of experience in managing academic research based start-ups and commercializing early stage inventions. She has been a member of the founding team in three start-up companies based in cutting edge science in Finland. Earlier Milla served for 9 years as a founding chief executive officer in a non-clinical stage, private drug discovery company, being responsible for IPR generation and management, leading research programs and partnerships, executing financing rounds and leading business development actions. Milla is well networked internationally and she has also worked as a postdoctoral researcher in biopharmaceutical projects at Eli Lilly and Company in the USA. Milla has led and commercialized several early stage drug discovery projects especially in the therapeutic areas of CNS diseases and oncology.
Milla holds Adjunct Professorship in neurobiology at University of Eastern Finland. She has a PhD degree from the same university. Milla gained her PhD thesis in collaboration with Stanford University and a mid-size biopharmaceutical company, Scios Inc., situated in Silicon Valley in California, USA. Since 2013 Milla has also served as a Board member of Finnish Bioindustries.
Milla is HIS's contact person in Viikki Campus.
Mobile +358 44 590 0603
Kajsa Kajander acts as Director, Business Development at HIS. Her main responsibility is to support and manage projects that aim for the commercialization of University of Helsinki owned intellectual property and knowhow.
Prior to joining HIS, Kajsa has worked almost 20 years in the industry. Her previous positions have familiarized her both with the health and wellbeing -area (pharmaceuticals, food supplements and medical devices) as well as with the food industry. Kajsa has been involved with the whole innovation process from idea generation to evaluation, development, funding and finally commercialization of product ideas. She has experience in international collaboration, networks and projects both in scientific research and in business relationships. Besides the innovation and development knowledge, she also has knowledge in quality and regulatory affairs particularly in the pharma, medical device and food sectors.
Kajsa’s educational background is in life sciences and she holds a PhD from the Institute of Biomedicine at the University of Helsinki.
Mobile +358 45 129 5576
At HIS, Pia Anttinen takes care of the various steps of the invention disclosure process, creation of immaterial property rights and management of the patent portfolio of the University of Helsinki. Pia is an experienced IP professional and has worked as a Patent engineer and most recently with regulatory and product stewardship issues. She also has experience from both product development and sales.
Pia holds a M.Sc. (Chem. Eng) from Helsinki University of Technology (now Aalto University)
Mobile +358 50 309 9796
Alexander Lagerman is responsible for managing and supporting business development activities in University of Helsinki’s commercialization projects, mainly within healthtech, but other life science related matters as well.
Alexander has a professional background in management consulting, sales, and entrepreneurship where he has worked with many different companies and innovation projects ranging from dental care and food innovation to lab consumables and drug candidates. He has also participated in different kinds of fundraising activities; contributing with financial planning, commercial development, and communication.
As educational background, Alexander holds a M.Sc. Business Creation and Entrepreneurship in Biomedicine from Chalmers School of Entrepreneurship and a B.Sc. Molecular Biology from the University of Gothenburg. Furthermore, he has studied independent courses in business administration, leadership, and marketing.
Contacts can be made in either English or Swedish.
Mobile: +358 50 563 0238
Petri Junttila identifies inventions stemming from University of Helsinki faculties of social and education sciences and arts. He assesses commercial potential of the inventions, and supports researcher teams in leveraging their innovations’ impact through funded commercialisation projects. To promote invention activity, Petri shares knowhow in methods, routes and opportunities of commercialisation within the faculties.
For over 10 years, Petri has been supporting numerous small and large, private and public organisations in business development and analysing their operational environment. He has worked e.g. as an M&A consultant at EY, and managed /co-founded the digital service development and brand design partner Nórr Design. Petri has experience in establishing and managing a business, as well as in sales and fund raising.
Petri holds an MSc Econ degree in Entrepreneurship and Management from Aalto University. Additionally, he completed IDBM-minor studies that promote multidisciplinary and customer-oriented business development. Petri also studied international business and management in the UK, USA and Germany.
Mobile +358 40 775 7852
Gen Tamjar evaluates, promotes and commercialises new research-related inventions at the University of Helsinki, with a particular focus on drug discovery and therapeutic development projects.
Gen has worked as a post-doctoral scientist at the MRC Protein Phosphorylation & Ubiquitylation Unit at the University of Dundee in the structural biology of neurodegenerative disease. Subsequently she was appointed Scientific Liaison Manager for the Drug Discovery Unit at the University of Dundee, a flagship UK endeavour with leading experts from the pharmaceutical industry. In 2018, she was recruited to the University of Helsinki, Finland as a Senior Advisor in Business Collaboration.
Gen has an extensive multidisciplinary background in biomedical research, starting from her undergraduate studies in Chemistry at Lomonosov Moscow State University. She subsequently obtained MSc and PhD degrees in the Molecular Biology & Biomedicine Program at CIC bioGUNE and the University of Basque Country, Spain, specializing in structural biology of trinucleotide repeat disorders. In 2017, she was named one of 5 UK Scientists to be awarded LifeArc-AUTM Technology Transfer Fellowship.
Mobile +358 50 377 3384
Eveliina Jutila is responsible for evaluating invention disclosures and identifying potential business or commercial opportunities of research results arising from the field of physical sciences at the University of Helsinki.
Eveliina has many years of experience in both basic and applied research at Aalto University and in immaterial property law studies at Hanken School of Economics. In her research, she has developed highly wicking porous coatings for microfluidic analytical and medical applications and characterized and tested coatings and coated samples among other things. Eveliina has also collaborated with the researchers of the division of Pharmaceutical Chemistry and Technology of the University of Helsinki.
Eveliina has Ms.c. (Tech) degree in papermaking and printing from Aalto University. She studied industrial management and strategic management as a minor. Currently she is finishing her PhD at Aalto University in the research group for Printing Technology and her studies at Hanken School of Economics in the master’s degree programme for Intellectual Property Law. Eveliina has also studied international management, marketing and economics at Otago University in New Zealand.
Mobile +358 50 476 3457
Andrea Dichlberger is involved in the identification, evaluation and verification of life science inventions with commercial potential. She is supporting and guiding University of Helsinki scientists all the way from idea to translation.
Andrea is a passionate life science professional with over 10 years of international experience in academic and non-academic biomedical research. She has strong expertise in lipid cell biology and lipid-related diseases. During her post-doctoral training, Andrea worked on human stem cell-derived mast cells in atherosclerosis and lipid-mediated inflammation at the Wihuri Research Institute, Helsinki, Finland and the University of Graz, Austria. Thereafter, she was recruited to the Centre of Excellence ProLipids at the University of Helsinki, where she specialized in the function of lipid-protein interactions in cancer, exosome biology, and lysosomal disorders. In addition, she was appointed as the research coordinator of the CoE ProLipids.
Andrea obtained her PhD in Natural Sciences at the Medical University of Vienna, Austria. She was awarded an Erwin-Schrödinger-PostDoc fellowship from the Austrian Science Fund. Moreover, she is trained in project management, interdisciplinary research coordination, strategic planning and development.
Mobile +358 45 179 0200
Ilona Kotala is responsible for the private partner engagement and business development of iCAN – Digital Precision Cancer Medicine flagship. In addition, Ilona's responsibilities include evaluating, protecting, and promoting commercialization of cancer research inventions at the University of Helsinki.
Ilona has over 13 years of experience in sales and marketing in both domestic and export trade. Commercial experience has accumulated in a variety of industries from renewable energy, to diagnostics and pharmaceuticals industries. Prior to her commercial career, Ilona worked as a researcher at the University of Helsinki. Ilona has experience in agile working practices and is a Certified Scrum Master®.
Ilona holds a Master's degree in Biochemistry from the University of Helsinki and has further developed her commercial skills through numerous independent courses.
Mobile: +358 40 535 7830
City centre campus Tiedekulma. Yliopistonkatu 4, 00100 Helsinki
Viikki campus Latokartanonkaari 3, 00790
Kumpula campus Pietari Kalmin Katu 5. 00560, Exactum
Meilahti campus Terkko Health Hub. Haartmaninkatu 4, Building 14
Helsinki Innovation Services Ltd
P.O. Box 53
FI-00014 University of Helsinki
Helsinki Innovation Services Ltd
P.O. Box 176
E-invoicing address: 003723985084
VAT number: FI23985084